Back to all studies
CompletedNCT02744989

STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia

This study is completed. It focuses on schizophrenia and currently lists study information in France and Monaco.

Schizophrenia, Mental DisordersDeviceFrom 18 Years to 65 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether brain stimulation may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may take part in brain stimulation, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in France and in Monaco.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about how many sessions are required and who delivers them, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: May 30, 2016
Recruitment status
Completed
Enrollment listed in the registry
141
Sponsor
Hospices Civils de Lyon
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
France, Monaco
Age range
From 18 Years to 65 Years
Official registry ID
NCT02744989
Official title
STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia (SCH)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT02744989. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

France · 9 sites
  • Centre Hospitalier Le Vinatier - Service de Psychiatrie Adulte
    Bron
    Site status: Not listed — confirm with the team
  • Centre Esquirol - CHU de Caen - Service de Psychiatrie Adulte,
    Caen
    Site status: Not listed — confirm with the team
  • CHU de Clermont-Ferrand - Pôle de Psychiatrie B
    Clermont-Ferrand
    Site status: Not listed — confirm with the team
  • Hôpital Fontan - CHRU de Lille - Pôle de Psychiatrie
    Lille
    Site status: Not listed — confirm with the team
  • Hôpital Edouard Herriot - Service d'Urgences Psychiatriques
    Lyon
    Site status: Not listed — confirm with the team
  • Hôpital de la Colombière - CHU Montpellier - Service de Psychiatrie Adulte
    Montpellier
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Saint-Anne - Service de Psychiatrie Adultes
    Paris
    Site status: Not listed — confirm with the team
  • CHU de St-Etienne - Service d'Urgences Psychiatriques
    Saint-Etienne
    Site status: Not listed — confirm with the team
  • CHRU de Tours - Clinique Psychiatrique Universitaire
    Tours
    Site status: Not listed — confirm with the team
Monaco · 1 site
  • Centre Hospitalier Princesse Grace - Service de Psychiatrie
    Monaco
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring brain stimulation for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study involving Neuroconn or Neuroelectric tDCS stimulator, Sham tDCS. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Hospices Civils de Lyon, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me